Investigative Drug Compounds/Therapies

*Differential treatment effects of TNX- 102 SL, a sublingual formulation of cyclobenzaprine, on dissociative symptoms of derealization and depersonalization in a military-related PTSD population: retrospective analysis of a double-blind randomized study** Presenters: Sullivan GM Affiliations: Tonix Pharmaceuticals, Inc Objective: Dissociative symptoms are associated with trauma disorders including posttraumatic stress disorder (PTSD). This is retrospective analysis […] The post Investigative Drug Compounds/Therapies appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Tags: Adverse Events in Psychiatry Brief Report Source Type: research